Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
05/2003
05/01/2003CA2464344A1 Ee3-protein family and corresponding dna sequences
05/01/2003CA2464261A1 Apomorphine-containing dosage form for ameliorating male erectile dysfunction
05/01/2003CA2464254A1 Inhibitors of post-proline cleaving proteases
05/01/2003CA2463311A1 Androgen receptor modulators and methods of use thereof
05/01/2003CA2463101A1 Azole derivatives and pharmaceutical compositions containing them
05/01/2003CA2461543A1 Sperm factor sequences
04/2003
04/30/2003CN1414965A Sulfonamides and derivatives thereof that modulate the activeity of endothelin
04/30/2003CN1414960A Substituted piperidines, medicaments containing these compounds, and methods for production thereof
04/30/2003CN1414871A Placental human necerokinin B precursor
04/30/2003CN1414860A Treatment of infertility
04/30/2003CN1413696A Suppository for treating gynecopathy and its preparation technology
04/30/2003CN1413694A Method for preparing
04/30/2003CN1413687A Medicinal cleaning solution for gynecopathy
04/30/2003CN1413683A Medicine for treating gynecopathy
04/30/2003CN1413652A Specific remedy for hysteromyoma and preparing method
04/30/2003CN1413645A Composite medicine for treating lumbodynia and method for preparing medicinal cup thereof
04/30/2003CN1413616A Pueraria root and application of its extract in preparing medicine for promoting mammogenesis, uterus development and raising lactation of breast feeding women
04/30/2003CN1413607A Medicine for treatment of gynecopathy
04/30/2003CN1106850C Medical capsule for reinforcing vital energy of kidney and making body stronger
04/29/2003US6555700 1,3-propane diol esters and ethers and methods for their use in drug delivery
04/29/2003US6555651 Ligand binding site of rage and uses thereof
04/29/2003US6555570 Growth hormone secretagogous with improved bioavailability
04/29/2003US6555559 5,6,7-trinor-4,8-inter-m-phenylene PGI2, derivative and drugs containing the same
04/29/2003US6555377 Process for production of mammalian cell lines
04/29/2003US6555131 Solid solution of a copolymer of ethyl acrylate and methyl methacrylate containing about 5% trimethylammonium ethyl methacrylate chloride as the sole (meth)acrylate copolymer and an ester of a weak acid as plasticizer
04/24/2003WO2003034028A2 Methods for identifying and using modulators of estrogen related receptor gamma
04/24/2003WO2003033518A1 Steroidal compounds for inhibiting steroid sulphatase
04/24/2003WO2003033487A1 Piperidine- and piperazineacetamines as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
04/24/2003WO2003033481A1 Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them
04/24/2003WO2003033472A1 Quinoline or quinazoline derivatives inhibiting auto- phosphorylation of fibroblast growth factor receptors
04/24/2003WO2003033470A1 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
04/24/2003WO2003033456A1 NOVEL β-PHENYL-α-OXYSUBSTITUTED PROPIONIC DERIVATIVES: PROCESS FOR ITS PREPARATION AND THEIR USE IN THE PREPARATION OF PHARMACEUTICALLY IMPORTANT COMPOUNDS
04/24/2003WO2003032991A1 N-aroyl piperazine derivatives as orexin receptor antagonists
04/24/2003WO2003032989A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors
04/24/2003WO2003032987A1 2'-methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2003WO2003032918A2 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors
04/24/2003WO2003032751A1 Alkanoyl l-carnitine metal salts and dietary supplements
04/24/2003WO2002068406A3 Substituted amine derivatives and their use for the treatment of angiogenesis
04/24/2003WO2002066018A3 Transdermal therapeutic system containing testosterone and method for the production thereof
04/24/2003WO2002064748A8 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
04/24/2003WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors
04/24/2003WO2002056875A3 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance
04/24/2003WO2002053137A3 Pharmaceutical composition for treatment of phimosis using topical corticosteroid
04/24/2003WO2002046383A3 Protein modification and maintenance molecules
04/24/2003WO2001078796A3 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor
04/24/2003US20030078303 Methods of treating and preventing sexual dysfunction using (+) sibutramine in combination with phosphodiesterase inhibitors
04/24/2003US20030078300 Fused bicyclic or tricyclic amino acids
04/24/2003US20030078284 Materials and methods for the treatment of depression
04/24/2003US20030078279 For therapy and prophylaxis of pain, central nervous system disorder or the like in mammalian subjects
04/24/2003US20030078278 Spiropiperidine compounds as ligands for ORL-1 receptor
04/24/2003US20030078275 For therapy of cancer, diabetes and Alzheimer's disease
04/24/2003US20030078270 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
04/24/2003US20030078252 Used to treat abnormal cell growth and central nervous system disorders
04/24/2003US20030078239 Ketone compounds and compositions for cholesterol management and related uses
04/24/2003US20030078236 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
04/24/2003US20030078232 A stimulants for bone marrow cell proliferation, countering the toxic side effect of drugs, in particular chemotherapeutic drugs, such as leukopenia and neutropenia
04/24/2003US20030078214 Phytooestrogen selected from genistein, daidzein; for promoting health in cases of cancer, pre-menstrual syndrome, menopause or hypercholesterolaemia
04/24/2003US20030078200 Treating a DSM-III disorder by administering to a mammal a peptide or a peptidomimetic thereof to reduce or eliminate symptoms of the DSM-III disorder
04/24/2003US20030077734 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
04/24/2003US20030077705 Nucleotide sequences coding polypeptide for use in the treatment of inflammation and ischemia-reperfusion injury
04/24/2003US20030077638 MID 4460, a human tyrosine phosphatase family member and uses therefor
04/24/2003US20030077271 Use of coagulation factor VII-activating protease for the prophylaxis and therapy of vasoproliferative disorders
04/24/2003US20030077246 TNFr/OPG-like molecules and uses thereof
04/24/2003US20030077243 Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use
04/24/2003CA2463729A1 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors
04/24/2003CA2463686A1 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them
04/24/2003CA2463685A1 Novel .beta.-phenyl-.alpha.-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds
04/24/2003CA2462441A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors
04/23/2003EP1304378A1 ARL-2 for fertility control
04/23/2003EP1304334A1 Novel antiandrogenic agent
04/23/2003EP1304324A1 Serotonin reuptake inhibitors
04/23/2003EP1304101A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications
04/23/2003EP1303619A1 A novel human soluble secreted endopeptidase (sep) for the treatment of sexual dysunfction
04/23/2003EP1303541A1 Gel compositions containing metronidazole
04/23/2003EP1303522A2 Biologically active macrolides, compositions, and uses thereof
04/23/2003EP1303521A1 Tetrahydro-heterocycloazepinyl pyrimidine derivatives
04/23/2003EP1303507A1 Pyrimidine derivatives
04/23/2003EP1303506A1 6-heteroarylphenanthridines
04/23/2003EP1303486A1 Pyrrolidine derivatives as metalloprotease inhibitors
04/23/2003EP1303485A1 Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme
04/23/2003EP1303304A2 Pharmaceutical combinations for treatment and prevention of diabetes mellitus
04/23/2003EP1303284A1 Compositions and methods for the treatment of skin damage
04/23/2003EP1303270A1 Method for treating cryptorchidism
04/23/2003EP1242445B1 14,15-cyclopropanosteroids of the 19-norandrostane series, method for producing said compounds and pharmaceutical preparation containing said compounds
04/23/2003EP1242009A4 Tissue sensitizing compounds for females with methods and apparatus for the delivery of these compounds
04/23/2003EP1222183B1 Benzopyran derivatives
04/23/2003EP1220863B1 Purine derivatives
04/23/2003EP1094807B1 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies
04/23/2003EP0956022B1 Hormonal composition consisting of an oestrogen compound and of a progestational compound
04/23/2003EP0764021B1 Uterine fibroid treatment
04/23/2003CN1413249A Human heparanase-related polypeptide and nucleic acid
04/23/2003CN1413219A Molecular structure of RHD negative genes locus
04/23/2003CN1413207A 5-membered ring heterocyclic compounds with nitrogen
04/23/2003CN1413206A Non peptide tachykinin receptor antagonists
04/23/2003CN1413116A Pharmaceutical composition for preventing and treating erectile impotence using purified sumsoo extract
04/23/2003CN1411863A Clematis liquor
04/23/2003CN1411854A Body-strengthening sexual health-care preparation (pill) for old people
04/23/2003CN1411836A Carthamus flower medicated liquor
04/23/2003CN1411809A Usage and composition of pyridine onium derivative for curing application
04/23/2003CN1411800A Cosmetic composition and method